Theriva Biologics, Inc. (TOVX) Form 8-K Material Events
Theriva Biologics, Inc. (TOVX) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TOVX
CIK: 894158
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerRyan Jones
Audit LocationRaleigh, North Carolina, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14A | 2026-10-09 | 2026-10-09 | PRE 14A | 0001104659-26-115074 | View SEC Doc Filr Page |
| S-8 | 2026-08-24 | — | FORM S-8 | 0001104659-26-100340 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001104659-26-093786 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | FORM 8-K | 0001104659-26-093782 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001104659-26-091674 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-03 | FORM 8-K | 0001104659-26-090064 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-07 | FORM 8-K | 0001104659-26-080962 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-29 | 2026-08-03 | DEF 14A | 0001104659-26-078859 | View SEC Doc Filr Page |
| ARS | 2026-06-29 | 2025-12-31 | ARS | 0001104659-26-078961 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-18 | 2026-06-18 | PRE 14A | 0001104659-26-075756 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | FORM 8-K | 0001104659-26-072633 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-05 | FORM 8-K | 0001104659-26-070966 | View SEC Doc Filr Page |
| 10-Q | 2026-05-05 | 2026-03-31 | 10-Q | 0001104659-26-055689 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-05 | FORM 8-K | 0001104659-26-055679 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-05 | DEF 14A | 0001104659-26-052960 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-20 | 2026-04-20 | PRE 14A | 0001104659-26-045553 | View SEC Doc Filr Page |
| 8-K | 2026-04-17 | 2026-04-17 | FORM 8-K | 0001104659-26-044906 | View SEC Doc Filr Page |
| 8-K | 2026-04-09 | 2026-04-09 | FORM 8-K | 0001104659-26-041507 | View SEC Doc Filr Page |
| 8-K | 2026-03-23 | 2026-03-23 | FORM 8-K | 0001104659-26-033051 | View SEC Doc Filr Page |
| DEF 14A | 2026-03-16 | 2026-04-09 | DEF 14A | 0001104659-26-028593 | View SEC Doc Filr Page |
| 10-K | 2026-03-12 | 2025-12-31 | 10-K | 0001104659-26-026767 | View SEC Doc Filr Page |
| 8-K | 2026-03-12 | 2026-03-12 | FORM 8-K | 0001104659-26-026765 | View SEC Doc Filr Page |
| PRE 14A | 2026-03-04 | 2026-03-04 | PRE 14A | 0001104659-26-023448 | View SEC Doc Filr Page |
| 8-K | 2026-02-18 | 2026-02-17 | FORM 8-K | 0001104659-26-016792 | View SEC Doc Filr Page |
| 8-K | 2026-02-12 | 2026-02-11 | FORM 8-K | 0001104659-26-013907 | View SEC Doc Filr Page |